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Abstract
Background: The σB protein of Muscovy duck reovirus (DRV), one of the major structural proteins, is able to induce 
neutralizing antibody in ducks, but the monoclonal antibody (MAb) against σB protein has never been characterized.
Results: Four hybridoma cell lines secreting anti-DRV σB MAbs were obtained, designated 1E5, 2F7, 4E3 and 5D8. 
Immunoglobulin subclass tests differentiated them as IgG2b (1E5 and 4E3) and IgM (2F7 and 5D8). Dot blot and 
western blotting assays showed that MAbs reacted with His-σB protein in a conformation-independent manner. 
Competitive binding assay indicated that the MAbs delineated two epitopes, A and B of σB. Immunofluorescence assay 
indicated that the four MAbs could specifically bind to Vero cells infected with DRV and σB was distributed diffusely in 
the cytoplasma of infected cells. MAbs had universal reactivity to all DRVs tested in an antigen-capture enzyme-linked 
immunosorbent assay.
Conclusion: Results of this research provide important information about the four monoclonal antibodies and 
therefore the MAbs may be useful candidate for the development of a MAb capture ELISA for rapid detection of DRVs. 
In addition, it showed that the σB protein was located in the cytoplasma of infected cells by immunofluorescence assay 
with MAbs. Virus isolation and RT-PCR are reliable way for detection of DRV infection, but these procedures are 
laborious, time consuming, and requiring instruments. These obvious diagnosis problems highlight the ongoing 
demand of rapid, reproducible, and automatic methods for the sensitive detection of DRV.
Background
The Muscovy duck reovirus (DRV) consists 10 segments
of double-stranded RNA (dsRNA) packaged into a non-
enveloped icosahedral double-capsid shell [1,2]. The
genomic segments can be separated into three size
classes: large (segments L1-L3), medium (segments M1-
M3), and small (segments S1-S4) [1,3,4]. DRV is an
important poultry pathogen associated with a variety of
clinical syndromes in ducks [5-7]. DRV could cause high
morbidity and up to 50% mortality in ducklings [3,8] and
recovered ducks are markedly stunted in growth.
All avian reovirus (ARV) encoded proteins including at
least 10 structural proteins (λA, λB, λC, μA, μB, μBC, μ1C
σC, σA, and σB) and 4 nonstructural proteins (μNS, P10,
P17, and σNS). The σB protein of DRV encoded by S3
gene segment is structurally related to the σ3 protein of
mammalian or σB of ARV [9-12] and may be functional
related. The σB protein is a major constituent of the outer
capsid and, like σC, is exposed to the surface of the virion
[2]. σB protein induce group-specific neutralizing anti-
body, while protein σC induces type-specific neutralizing
antibodies [4].
Many methods have been developed for the diagnosis
of DRV or ARV infections. Agar gel immuno-diffusion
test (AGID)[13,14], Serum neutralization test (SN) [3,15],
and enzyme-linked immunosorbent assay (σB-σC-
ELISA) [12,16] are designed to detect antibodies to DRV
or ARV. Immunofluorescent staining [6] offers the direct
detection of viral antigens in tendon tissues. Recently, the
one step RT-PCR method for the detection of ARV, DRV
and goose reovirus (GRV) RNA from the cell culture and
specimens [17] has been developed, providing a sensitive
tool for diagnosis of different bird species reovirus infec-
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tions. However, these methods possess some general
problems, as they are time-consuming and labor-inten-
sive, require sophisticated instruments.
I n  t h i s  s t u d y ,  f o u r  m o n o clonal antibodies (MAbs)
directly against bacterially expressed σB protein of DRV
were produced and characterized. Due to its universal
reactivity to DRVs, it is an ideal candidate for use in an
antigen-capture enzyme-linked immunosorbent assay
(ELISA) for clinical diagnosis.
Methods
Cell and virus
The DRV S12 and several field isolates (S14, 044, F, and
C4 strains) were used in this study [17]. All the DRV iso-
lates were propagated in duck embryo fibroblasts (DEF)
or Vero cells. The supernatant obtained by centrifugation
of these lysates was treated with 1% Triton X-100 and
used as a crude antigen for the antigen-capture ELISA.
Antigen preparation
σB protein used for the production and characterization
of MAbs were synthesized in Escherichia coli BL21 (DE3)
as described before [12]. The expressed His-σB and 6.7
His proteins were purified by using Ni-NTA kit (Qiagen,
Valencia, CA). This 6.7 kDa protein was used as a nega-
tive control during screening specific antibodies to σB in
an ELISA.
Monoclonal antibodies production
BALB/C mice were immunized intraperitoneally with 30
μg of antigens containing σB fusion protein in complete
Freund's adjuvant and boosted twice with the same
amount of antigens in incomplete Freund's adjuvant at 2
weeks intervals. Six weeks after the initial immunization
and 4 days before the mice were sacrificed for the prepa-
ration of hybridoma, final boost was carried out in the
same route with 30 μg of the same antigens. MAbs were
produced using techniques similar to that described pre-
viously [18]. Briefly, spleens were removed from mice
immunized with antigens containing σB as described
above. Splenocytes were fused with NS1 myeloma cells.
Hybridoma cell lines secreting antibodies against σB were
screened and subcloned at least three times by a limiting
dilution method and ascitic fluids were prepared with the
cloned hybridoma in BALB/C mice.
Serological screening
Hybridoma culture supernatants or mouse ascetic fluids
were screened for antibodies in an indirect ELISA as
described for antibody binding assay. Antibodies that
bound to σB protein but failed to bind 6.7 kDa protein
were considered to be positive to σB.
Isotyping
I s o t y p e s  o f  t h e  p r o d u c e d  M A b s  w e r e  d e t e r m i n e d  b y
using Mouse Immunoglobulin isotyping kit (Zymed Lab-
oratories, Inc.) according to the manufacture's instruc-
tion.
Western blot assay and Immuno-dot binding assay
To examine whether S12 σB MAbs recognize the linear
epitope of S12 σB protein, Western blotting was used to
examine the binding ability of MAbs to denatured His-σB
proteins. Purified His-σB protein was subjected to 10%
SDS-PAGE and transferred to nitrocellulose membranes.
The membranes were probed with different MAbs fol-
lowed by a secondary HRP-conjugated goat anti-mouse
antibody (KPL, MD, USA). His-σB and His proteins (as
negative control) were used for dot blotting assays.
Approximately 1 μg antigen was diluted with TNE buffer
and spotted onto nitrocellulose membrane. The mem-
branes were probed with the same MAbs as for western
blot.
Detection of native σB protein by immunofluorescence 
assay
Vero cells were infected with DRV S12 strain (10 M.O.I.)
and incubated at 37°C for 24 h. The cells were fixed with
cold methanol for 10 min and then probed with different
anit-σB MAbs and negative normal mouse serum for 1 h
at 37°C. Bound antibodies were visualized using fluores-
cent conjugated antibodies against mouse IgG (1:500
dilutions) under a fluorescence microscope.
Coupling of horseradish peroxidase to monoclonal 
antibodies
Immunoglobulin fractions were isolated from ascetic flu-
ids by precipitation at 4°C with an equal volume of satu-
rated ammonium sulfate (pH 7.0), and then purified using
an affinity column of protein G-agarose (Boehringer
Mannheim). Antibodies were coupled to HRP by the
periodate method [19] and stored at -20°C.
Determination of MAbs titers
The titres of MAbs were determined using an ELISA.
Expressed His-σB protein was coated into each well of
plates with 0.1 μg at 37°C for 2 h. The plates were washed
three times with washing buffer (0.01 M phosphate-buff-
ered saline, pH 7.2, 0.05% Tween 20) and blocked with
100 μl TNE buffer containing 2.5% bovine serum albu-
min. After washing, two-fold serial dilutions of 1 μg/ml
uncoupled or HRP-coupled MAbs were added and incu-
bated for 1 h. For uncoupled MAbs, an additional 50 μl
HRP-coupled goat anti-mouse antibodies were added.
The absorbance value was read at 405 nm with a
Microplate Reader (BIO-RAD). The level of binding forLiu et al. Virology Journal 2010, 7:133
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the relative activity was measured from the resulting
dose-response curve.
Antibody binding assay
To carry out the competitive binding assay, the amount of
binding in the ELISA was determined for all MAbs
uncoupled with HRP or coupled [20]. Briefly, for HRP-
unconjugated MAb determination, ELISA plates were
coated with 0.1 μg purified σB per well at 37°C for 2 h.
After washing, 100 μl of TNE buffer containing 2.5%
bovine serum albumin was added to each well to saturate
all unbound sites. After washing, 100 μl of purified MAb
serially diluted with TNE buffer containing 1% bovine
serum albumin was added and incubated for 2 h at 30°C.
After washing, 50 μl of a 1:500 dilution of HRP-conju-
gated goat anti-mouse IgG serum was added and incu-
bated for another 1 h. The enzymatic activity was
determined after 20 min of incubation by the addition of
30 ml of 1% sodium azide. The absorbance was measured
at 405 nm. For HRP-conjugated MAb determination, the
same procedures were carried out except that HRP conju-
gated MAbs were directly added to the antigen coated
plates without using the HRP-conjugated goat anti-
mouse antiserum. The level of maximum binding for the
relative activity measurement and the MAb concentra-
tion at which 50% binding occurred were obtained from
the resulting dose-response curve.
Competitive binding assay
Competitive binding assay were similarly to the proce-
dures described above, except for a mixture of the HRP-
conjugated MAbs at twice the concentration, giving half
maximal binding. Unconjugated, competing antibodies at
different concentrations were also added simultaneously.
The competition between two MAbs against the same
site was related to their relative avidities and concentra-
tions. A spectrum of dose-related interference was tested.
Non-specific binding without antigens was used to repre-
sent the background. The degree of competitive binding
was measured from the absorbance at 405 nm in the pres-
ence or absence of unconjugated competing antibodies.
Competition was rated as strong (++) if it was more than
60%, significant (+) if it was more than 30%, and negative
(--) if it was less than 30%.
Cross-reactivity of the MAbs to heterologous DRV strains
To study the monoclonal antibodies for their cross-reac-
tivity with various DRV strains in an antigen-captured
enzyme-linked immunosorbent assay (ELISA), four DRV
field isolates were tested. MAbs (1E5 and 2F7) were used
to prepare an antigen-capture ELISA and compared with
the polyclonal antibody against DRV S12. Briefly, 100 μl
mouse anti-σB polyclonal antibodies (1:200) were coated
onto ELISA plates. After washing and blocking, 100 μl of
cell extracts of DEF infected with each DRV isolates or
from mock-infected cells were added and incubated for 1
h at 37°C. For the reaction of MAbs, 50 μl of HRP-conju-
gated MAbs (1:1000) were added as the primary antibody.
T o  d e t e r m i n e  i f  σ B  p r e s e n t  i n  e a c h  c e l l  e x t r a c t s  f r o m
DEF/Vero infected with each DRV isolates was captured
by anti-σB antiserum, duck antiserum against DRV S12
and HRP-coupled goat anti-duck antiserum were used as
a primary and secondary antibodies, respectively. Absor-
bance was measured at 405 nm. Binding to the heterolo-
gous virus is expressed as percentage by taking the
absorbance obtained with DRV S12 in the reaction as
100. Binding was rated as strong if it was more than 50%,
significant if it was 25-50%, and negative if it was less than
25%.
Results
Production and general characterization of MAbs
At 3 weeks after cell fusion, the hybridoma cell lines
secreting anti-σB antibody were screened by ELISA. Four
MAbs directed against σB were selected for subcloning at
least three times using the limiting dilution method.
Hybridomas were selected to produce MAbs in mice and
the ascitic fluids were used for further characterization.
The isotypes of MAbs were IgG2b (1E5 and 4E3) and IgM
(2F7 and 5D8), respectively. Concentrations of immuno-
globulin ranged from 0.35 to 15.76 μg/ml.
Effect of denaturation of σB on MAb recognition
The expressed His-σB proteins were denatured by boiling
in SDS and 2-mercaptoethanol, and subjected to western
blotting; four MAbs still recognized them (Fig. 1). To
determine if a native structure of σB is required for anti-
body binding, the native antigens containing σB was
examined by using immuno-dot binding assay. All MAbs
recognized the native structure of σB in TNE buffer (Fig.
2), but did not react with His proteins.
Figure 1 Reactivity of S12 σB MAbs to E coli expressed pET30-σB 
and pET30a vector. Lane 2, 4, 6, and 8 E. coli expressed pET30-σB; lane 
3, 5, 7, and 9 E.coli expressed pET30a vector; lane 2 and 3 MAb 1E5; lane 
4 and 5 MAb 4E3; lane 6 and 7 MAb 2F7; lane 8 and 9 MAb 5D8, respec-
tively.
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Detection of native σB protein by immunofluorescence 
assay
Immunofluorescence assay was performed on S12
infected Vero cells to assess whether the S12 σB MAbs
recognize the native-form of σB protein. Four σB MAbs
strongly reacted with S12 infected cells, whereas unin-
fected cells showed no reaction (Fig. 3). The fluorescence
signals of the MAbs were predominantly visualized in the
cytoplasm of S12 infected cells. This indicated that all
MAbs were able to detect native-form σB protein in S12
infected cells.
Avidity of MAbs to σB
The amount of MAbs bound to the σB proteins can be
quantified within the linear range of absorbance. This
offers an estimation of the relative avidity of MAbs for
their binding proteins. Binding degrees of MAbs to His-
σB using ELISA titration indicated that all MAbs satu-
rated at dilutions from 10-1  and 10-1.8. Four MAbs
retained their binding capacity after coupling to HRP, and
the dilution range of saturation was 101 to 102. No appar-
ent saturation appeared in the remaining HRP-MAbs
(data not shown).
Mapping of the epitopes
The proper concentrations for the competitive binding
assay were determined using dose-response curves plot-
ted for unconjugated and HRP-conjugated MAbs (data
not shown). Each of the four MAbs was used both as a
competitor and as HRP-conjugated probe. The percent-
age of competition was normally 100% in the presence of
a saturating unlabeled homologous antibody. Two dis-
tinct epitopes on σB were found and designated A and B
(Table 1). 1E5, 4E3, and 5D8 all belong to epitope A, while
2F7 belong to epitope B.
Detection of DRV σB antigens
MAbs 1E5 and 2F7, representing MAbs recognizing
epitopes A and B, respectively, were selected for testing
their cross-reactivity with other heterologous DRV
strains in the ELISA. The relative binding to heterologous
D R V  i s o l a t e s  i s  e x p r e s s e d  a s  p e r c e n t a g e  b y  t a k i n g  t h e
A405 obtained with DRV S12 in the reaction as 100.
Binding was considered as strong if it was more than 50%,
significant if it was 25-50%, and negative if it was less than
25%. The results indicated that σB in cell extracts pre-
pared from DEF infected with each heterologous DRV
strains was captured by anti-σB antiserum. There are no
appreciable differences in the binding of the different
MAb's tested. As expected, negative results were
obtained using the mock infected DEF (< 25%). There-
fore, MAbs 1E5 and 2F7 strongly recognized all tested
virus strains, suggesting that epitopes A and B are com-
monly present among σB of DRV strains and also indicat-
ing MAbs 1E5 and 2F7 suitable candidates for the
diagnosis of DRV isolates.
Discussion
The results showed that the antigen preparations con-
taining the expressed His-σB protein of DRV could
induce the production of MAbs. After screening and sub-
cloning, the four MAbs directed against His-σB were iso-
lated and characterized. Analysis of immunofluorescence
assay indicates that these MAbs bound to the authentic
viral protein σB of DRV S12. Thus, the epitopes on the σB
recognized by these MAbs were also present on the viral
σB of DRV. As for the conformation of His-σB protein in
Figure 2 Dot blotting assays of MAbs to His-σB and His proteins. 
Lane 1, MAb 1E5; lane 2, MAb 4E3; lane 3, MAb 2F7; lane 4, MAb 5D8.
His-σB 
12 34
His 
       
Figure 3 Detection of S12 σB protein by indirect immunofluores-
cence assay on Vero cells infected with S12. No special fluorescence 
was found on normal cell (400 ×).
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antibody binding, all MAbs bound to the His-σB in its
native conformation. When SDS and 2-mercaptoethanol
were used to denature the σB-His protein, this binding
still remained, indicating that the recognized epitopes
were not affected by breaking of disulfide bonds. This led
us to suggest that the MAbs binding was conformation
independent.
The competitive binding assays were used to determine
epitopes of MAbs based on the notion that a MAb bind-
ing to a specific site can block the attachment of another
MAb to the same site. Two epitopes, A and B, inhibited
almost completely the binding of HRP-coupled MAbs
recognizing the same epitope, but no competition was
obtained among MAbs recognizing epitope A or B. It has
not been determined if the epitope A or B involves in any
biological functions, but they are highly conserved
among DRV strains as the MAbs could recognize both
epitopes on all virus strains tested.
DRV σB protein has one basic stretch (KKVSHYR,
amino acids 287-293), which is required for dsRNA-bind-
ing activity [21]. Thus, to illustrate whether the σB
responsible for dsRNA binding or not is currently being
investigated by the preparation of deleted mutant pro-
teins of DRV σB along with MAbs described here.
All of these MAbs could successfully detect native-form
σB protein in infected cells, as well as in viral particles.
Thus, these MAbs may be useful in the development of
sensitive methods used for the diagnosis of DRV, such as
immunoblot assay, immunofluorescence assay and anti-
gen-capture ELISA. Antigen-capture ELISA using anti-
virus antibodies has been an ideal choice for large screen-
ing, quantitative analysis of viral antigen or virus titer
because of its high sensitivity, reproducibility, and auto-
mation.
In this study, we generated four positive clones secret-
ing specific and highly reactive antibodies against DRV
σB protein in order to develop diagnostic methods. The
results reveal that the MAbs capture ELISA clearly differ-
entiates the samples between the DRV- and mock-
infected as demonstrated by absorbance values, suggest-
ing that non-specific reactions could be markedly
reduced in the MAb capture ELISA. Both MAbs (1E5 and
2F7) recognize DRV σB at different sites which are highly
conserved in all DRV strains tested in the present study.
Thus, MAbs (1E5 and 2F7) capture ELISA seems accept-
able as a screening method for the detection of DRV in
infected birds in future.
Conclusion
In summary, the results of this experiment provide
important information about the monoclonal antibodies
against Muscovy duck reovirus σB protein. Especially the
monoclonal antibodies could contribute for the develop-
ment of a MAb capture ELISA for rapid detection of
DRVs. In addition, it showed that the σB protein was
located in the cytoplasma of infected cells by immunoflu-
orescence assay with MAbs. Although virus isolation and
RT-PCR are reliable way for detection of DRV infection,
these procedures are laborious, time consuming, and
requiring instruments. These obvious diagnosis problems
highlight the ongoing demand of rapid, reproducible, and
automatic methods for the sensitive detection of DRV.
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Table 1: Results of competitive binding assay between MAbs against σB protein
Competitor HRP-labeled MAbs
1E5 4E3 58 2F7
Epitope A
1 F 5+ ++ ++ + - -
4 F 3+ ++ ++ + - -
5 D 8 + ++ ++ + - -
Epitope B
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